Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Post Approval, Multiple Centre, Open-Label, Non-Interventional, Registry Study to Evaluate Effectiveness of TheraSphere® in Clinical Practice in France

NCT04069468 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT04069468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04069468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Post Approval, Multiple Centre, Open-Label, Non-Interventional, Registry Study to Evaluate Effectiveness of TheraSphere® in Clinical Practice in France
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Completed
Start date
March 13, 2019
Completion date
December 31, 2024
Enrollment
1,247 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma